Frequent preventable emergency department (ED) 
Introduction
Preventable emergency department (ED) visits associated with chronic illness among the geriatric population (65 yrs +) are growing in number. In California, it was observed that ED visit rates were highest for renal disease (49%), diseases of the blood and blood-forming organs (43.8%), abdominal pain (30%), other undefined symptoms (27%), and hypertension (27%). 1 With 15% of all ED visits being made by patients at least 65 years and with the growing population of elderly population which is projected to increase from 14%, in 2012, to 20% in 2030;
2 the incidence of ED visits associated with chronic disease across the states of the United States will continue to rise. The rising number of preventable ED visits among the elderly will not only financially impact the healthcare system but may adversely affect the individual patients. For example, in a matched cohort study, Nagurney et al observed an increased risk of functional decline by 17% among patients who visited the ED when compared to patients who did not. 3 Although the result of the aforementioned observation is merely an association, it underscores the patient-related adverse outcomes associated with frequent ED visits among geriatric patients. It is noteworthy that among the elderly, medicationrelated problems are one of the significant reasons for increased ED utilizations. Therefore, it is reasonable to hypothesize that pharmacist intervention would improve ED utilizations. Although Pharmacist interventions have been shown to improve medication discrepancy, 4 limited, randomized studies have demonstrated the impact of pharmacist interventions with the reduction of preventable ED use. Consequently, some healthcare systems struggle to reduce readmissions using pharmacy services. Hence, the objective of this article is to discuss our process with implementing pharmacist-providers transitional model in the ED with the intent of elucidating pharmacist intervention principles and a pharmacist-driven, patient-care transitional model that would provide direction for other healthcare systems to improve ED visits among the elderly within their locality.
Our Experience with Implementation of Transitional Model of Care
In 2009, we conducted a pilot study to evaluate the effectiveness of a pharmacist-led implementation of medication reconciliation services and medication therapy management, with student pharmacist assistance. 5 The results of the study revealed a reduction in the frequency of combined ED visit and re-hospitalization among ED patients seen by student pharmacists under the direction of a pharmacist when compared to ED patients who followed the usual care (mean difference in number of visits: 25%, P = 0.047). 5 Although this pilot study was not a randomized clinical trial, the results of the pilot study was consistent with a randomized study published by Gillespie et al in Sweden. 6 In Gillespie et al study, they observed a 16% reduction of combined ED visits and hospital readmissions among patients seen by pharmacists when compared to patients who did not (estimate 0.84%; 95% confidence interval [CI], 0.72 -0.99).
Following the results of our pilot study, we conducted a randomized control study in order to further evaluate the impact of pharmacist provisions of medication reconciliation and medication-therapy management on primary care visits, ED visits and urgent care visits. 7 In this study, we observed an increased number of primary care visits (odds ratio [OR] 1.5; 95% [CI] 1.04 -2.1) and a reduction in the number of urgent care visits (OR 0.5; 95% CI 0.3 -0.9) among patients taking at least one chronic medication who were seen by a pharmacist compared to those who did not. 7 However, no difference was observed in the frequency of ED visits between the two groups. We believed that the lack of statistical significant differences observed in the number of ED visits between the two groups was related to other quality improvement projects implemented by the health systems due to the roll out of the Affordable Care Act. Nonetheless, we concluded that the increase in the number of primary care visits and the reduction of urgent care visits was a positive sign of transitioning patients towards appropriate use of primary care services, which may advertently lead to an improvement in ED utilizations. 7 Based on our positive experiences, we proposed that for the healthcare system to effectively improve preventable ED visits among elderly patients, ED pharmacist care model should integrate 4 fundamental intervention principles. These four fundamental intervention principles are as follows: 1.) Enhance the medication reconciliation process, 2.) Deprescribe (with respect to polypharmacy) 3.) Improve medication adherence, 4.) Improve patient medication education and counseling. The integration of the proposed intervention principles is based on the hypothesis that they are not independent of each other, and any deficiency in one of the intervention principles may lead to inappropriate ED utilization and adverse outcomes among the elderly. [8] [9] [10] [11] For example, though pharmacist provision of medication reconciliation alone has been shown to improve medication discrepancy, its sole application has not been shown to improve inappropriate ED utilizations. This is consistent with other principles when independently applied. Thus, highlighting the need to integrate the aforementioned four intervention principles in a pharmacist-care transitional model.
Description of the Process Model
Our patient care model (see Figure 1 ) systematically followed a stepwise approach and integrated into our ED triage process. It is noteworthy that some activities in the model, as will be described, either occurred simultaneously or concurrently. A description of the process is as follows:
Step 1. Patient's Profile Review: Upon presentation in the ED, Triage nurse alerts pharmacist for medication review. Five activities will occur concurrently at three different process levels as follows:
• Level 1: Pharmacist review of three important key elements: first, a review of past medical history; second, a history of current diseases and laboratory values (if available); third, review of past medication history (PMH) if available. The rationale for this interview or profile review is to correlate or identify any medication-related problem associated with history of present illness.
• Level 2: A trained Pharmacy technician or a student pharmacist will collect medication history.
• Level 3: ED Patient will be given a survey which has been psychometrically validated to proactively evaluate patient's medication-taking self-efficacy. This validated tool is known as the Okere-Renier Survey. 12 The OkereRenier survey will be used by the pharmacist to proactively identify any deficiency in attitude or perception that may potentially lead to medication non-adherence. This survey can either be completed by the patient or the caregiver.
Step 2. Verification of patient's medication history: the patient's medication history will be compared with the medication history obtained from a single community pharmacy or a multiple community pharmacy (if the patient has more than one pharmacy). When the latter activity occurs, the ED provider will enter the patient's room to conduct a medical screening exam.
Step 3. Medication Therapy Management: The ED Physician/Provider and Pharmacist will quickly analyze information obtained. Critical information to be discussed are as follows: medication discrepancies, adherence patterns, drug-drug interactions, drug-disease interactions, potential drug-related adverse outcomes/side-effects, possible labs/imaging that could be obtained to support decisions and opportunities to improve care. Finally, a potential medication optimization related to the patient's comorbidities and deprescribing will be discussed.
Stage 4:
Patient education/counseling: following step three, a pharmacist will provide medication information to the patient and a complete list of their accurate medication list. This will also be documented in the electronic health record (EHR). Information obtained from the Okere-Renier survey will be reviewed by the Pharmacist and will guide the pharmacist's approach in helping the patient improve his or her medicationtaking self-efficacy.
Stage 5: Discharge letter provided: in addition to a discharge letter being provided to the patient's primary care provider by the nurse, the pharmacist provides a short letter (usually less than a page) to summarize the patient's history of current illness, and to detail observed medication-related problems, the suggested approach to management and continued care after discharge. This is communicated to the primary care provider through electronic communication and included in the discharge letter sent by the provider. Finally, a copy of the letter written by the pharmacist is provided to the patient to aid with patient discussion with his or her primary provider. Most importantly, the content of this letter is also discussed with the patient prior to discharge. This latter activity is based on two rationales; first, the transfer of discharge letters (provided by ED providers) to the patient's outpatient provider is either not timely or lacks important information that would guide appropriate management and subsequently prevent readmissions. 13, 14 Secondly, discussing and providing the letter to the patients will empower them to discuss their care with their provider.
Discussion
Over the years, the primary objective of ED has evolved beyond treating critically ill patients to managing patients who have chronic diseases. With the elderly population being expected to increase exponentially in coming decades, the dire need to ameliorate inappropriate ED visit among the elderly population is widely acknowledged among healthcare organizations and policy makers.
As previously stated, many of the elderly that frequently visit the ED carry a high burden of chronic diseases, have multiple comorbidities and polypharmacy issues. 15 The proposed transitional model of care process is based on a premise that the integration of pharmacists in the ED, as a frontline clinician, leads to an improved comprehensive medication review and minimize medication discrepancies prior to ED discharge. This will ultimately improve the transition of care and lead to better health outcomes. Thus, the adoption of this model will enhance healthcare system's ability to creatively use a interprofessional approach in the care of the elderly in the ED.
A unique characteristic of this model of care process is the ability to integrate several intervention principles such as medication reconciliation process, medication review that would lead to de-prescribing and optimization of medication therapy, helping patients improve medication adherence, provision of patient medication education and discharge counseling. As evident in our studies, 5, 7 it creates opportunities for the ED pharmacist to enhance patients' self-efficacy during ED visit which will ultimately lead to better health outcomes. Additionally, the proposed transition of model of care can enhance the algorithm to improve the safety and effectiveness of transition of care, as developed by Kessler et al. 16 The aforementioned algorithm discussed the 5 step approach to transition of care in the ED, which involves minimizing interruptions, interprofessional approach, identification of high risk patients, identify the receiving patient and "closing the loop" which allowed time to address any questions. 16 Thus, this model can easily be integrated in the algorithm to provide a true interprofessional approach to care.
Design and implementation of this proposed model is not without challenges. One of the noteworthy challenges was identifying the most productive time to have a pharmacist present in the ED as the institution, prior to implementation of the model, did not have a 24-hour ED pharmacy service. A collaboration and discussion between the ED team and the pharmacy team went a long way, not only to identify the right time period for maximal patient outreach but to overcome other challenges that the healthcare systems may encounter. Additionally, allocation of resources and staffing adjustment were potential barriers. The creative integration of either pharmacy students or trained pharmacy technician and/or post-graduate pharmacy resident in the model is key to overcoming the issue of resource allocation and staffing adjustment.
Despite these challenges, one unique advantage of this model is its simplicity to implement or to adapt irrespective of the type of healthcare system such as rural or urban, academic or nonacademic healthcare system. However, more pragmatic clinical studies will be needed to further evaluate the effectiveness of the proposed pharmacist transition of care model in improving health outcome, quality of care measures and its ease of implementation.
Conclusion
As previously stated, some healthcare systems struggle to reduce readmission-using pharmacy services. Nonetheless, reducing preventable readmissions is feasible when pharmacists and providers (including mid-level providers) collaboratively provide direct patient care adeptly. Efficient provisions of direct patient care in the emergency department will be dependent on the patient-care process model established. We propose that any patient-care model established should foster integration of interdisciplinary team members and the four fundamental intervention principles.
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